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Purpose: Dry eye is the most common symptom of thyroid-associated ophthalmopathy in Hashimoto thyroiditis. Ocular surface inam-
mation, tear hyperosmolarity and overproduction of inammatory cytokines are responsible for the development of this process. In this
study, we aimed to investigate the relationship between thyroid functions and dry eye symptoms in patients with Hashimoto thyroiditis.
Materials and Methods: The patients,  diagnosed with Hashimoto thyroiditis (n:125), were included in this monocenter cross-sectional study.
The study population was divided into three groups: euthyroidism (Group–1, n:48), subclinical hypothyroidism (Group–2, n:38) and overt
hypothyroidism (Group–3, n:39). The groups were compared based on the presence of dry eye syndrome, Schirmer tests, OSDI scores of
patients with dry eye diagnosis and tear break-up time. The results were analyzed with ANOVA and Spearman’s correlation test. 
Results: No signicant difference was found in the frequency of dry eye syndrome between the groups (p = 0.1). There was no difference
in the Schirmer scores and tear break-up time measurements (p = 0.6 and 0.2). The severity of OSDI scores was signicantly milder in the
patients with dry eye diagnosis, in the euthyroid group (p = 0.03). Serum fT3 levels positively correlated with tear break up time measure-
ments (p = 0.004, r = 0.302) and negatively correlated with presence of dry eye syndrome (p = 0.03, r = –0.981). 
Discussion: Although dry eye symptoms tend to be  milder in euthyroid patients, the frequency of dry eye syndrome is similar in patients
with Hashimoto thyroiditis, independent of thyroid function status. 
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Amaç: Hashimoto tiroiditi tanısı olan hastalarda tiroid fonksiyonlarının durumu ile kuru göz semptomlarının şiddeti arasındaki ilişkinin de-
ğerlendirilmesi amaçlanmıştır. 
Gereç ve Yöntemler: Prospektif klinik çalışmaya 125 Hashimoto tiroiditi tanılı hasta dahil edilmiştir. Hastalar tiroid fonksiyon durumlarına
göre ötiroid (Grup–1, n:48), subklinik hipotiroid (Grup–2, n:38) ve aşikar hipotiroid (Grup–3, n:39) olmak üzere üç gruba ayrılmıştır. Kuru göz
tanısı, Schirmer testi, gözyaşı kırılma zamanı ve OSDI anket sonuçlarına göre konulmuştur. Kuru göz tanısı olan hastalarda semptomların
şiddeti OSDI anketlerine gore belirlenerek tiroid fonksiyon durumu ile ilişkisi araştırılmıştır. Verilerin analizinde ANOVA ve post-hoc Tukey testi,
korelasyon analizinde Spearman Korelasyon analizi kullanılmıştır.
Bulgular: Gruplar arasında kuru göz tanısının sıklığı arasında anlamlı fark izlenmedi (p = 0.1). Ötiroid grupta OSDI skorları belirgin olarak
daha düşük izlendi (p = 0.03). Serum sT3 düzeyleri ile gözyaşı kırılma zamanı arasında pozitif korelasyon (p = 0.004, r = 0.302) tespit
edildi. Ayrıca serum sT3 düzeylerinin kuru göz sıklığı ile negatif korelasyon gösterdiği izlendi (p = 0.03, r = –0.981).
Tartışma: Ötiroid hashimoto tiroiditi tanılı hastalarda, göz kuruluğu semptomları daha haf seyretmekte olsa da kuru göz sıklığının has-
himoto tiroiditi tanılı hastalarda tiroid fonksiyon durumundan bağımsız olarak benzer oranlarda görüldüğü tespit edilmiştir. 
Anahtar kelimeler: Kuru göz, OSDI, Hashimoto tiroiditi
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Introduction
Dry eye is one of the most common clinical problems with several
adverse effects on the quality of life (1, 2). This disorder may be a
manifestation of several systemic or autoimmune disorders in-
cluding autoimmune thyroiditis and hypothyroidism (3). Dry eye
syndrome may affect visual acuity and daily activities, along with
social and physical skills, resulting in significant decrease in the
quality of life (4, 5). Any defect in the lacrimal gland, eyelid, and the
ocular surface may lead to this syndrome (6).
Dry eye is also the most common finding of thyroid-associated
ophthalmopathy (TAO) (7) in thyroid disorders such as Graves’ dis-
ease and Hashimoto thyroiditis (8). TAO is defined as an autoim-
mune disease of the extraocular muscle tissue and the lacrimal
glands, characterized by extraocular myopathy, optic neuropathy,
and ocular surface inflammation (9). The exact etiopathogenesis
has been not established currently and several factors are consid-
ered to be responsible for the development of this disorder. The
most common factors are T cell-dependent ocular surface inflam-
mation, increased tear film evaporation and hyperosmolarity due
to proptosis, especially in Graves’ disease. Additionally, the effect of
several inflammatory cytokines such as IL1-α, IL-4, and IGF-1 may
play a role in this process (8). Recently, in addition to these factors,
thyroid hormone receptors β-1 (Thrb-1), which are located on
lacrimal glands, were found to be responsible for the development
of dry eye (10). These receptors are known to cause susceptibility
toward hypothyroidism, by converting the lacrimal glands as a tar-
get tissue for thyroid hormones. 
Although there exist a large number of studies involving the pres-
ence of dry eye in patients with Graves ophthalmopathy (7,9,11,12,),
the number of such studies in patients with Hashimoto thyroiditis
is still very limited. In this study, we aimed to investigate the rela-
tionship between thyroid functions and dry eye symptoms in pa-
tients with diagnosis of Hashimoto thyroiditis.
Materials and Methods
Study Group: A total of 125 patients (Females:115 and Males:10,
with a median age of 38 years, ranging between 18–75 years) who
were admitted to endocrinology and metabolism outpatient clinic,
between March 1, 2016 and June 1, 2016, with the diagnosis of
Hashimoto thyroiditis, were included in the study. The patients with
a history of thyroidectomy, eye or eyelid surgery, eye or eyelid ab-
normalities (proptosis, exophthalmos), prior diagnosis of dry eye
or additional eye pathology, the presence of a rheumatologic dis-
ease associated with dry eye syndrome (Sjogren’s disease,
rheumatoid arthritis) were excluded from the study groups. The pa-
tients were divided into three groups according to their thyroid
function levels and clinical situations such as: euthyroid patients
(Group-1; asymptomatic with normal free T4 (fT4) and thyroid stim-
ulating hormone (TSH) levels, n:49, F/M:46/2), subclinical hypothy-
roid patients ( Group-2; asymptomatic with normal fT4 and
elevated TSH levels (5–10 mIU/L), n:38 , F/M:33/5) and patients with
overt hypothyroidism (Group-3; symptomatic with normal fT4 and
elevated TSH levels (>10 mIU/L) or decreased fT4 and elevated TSH
levels (>5 mIU/L), n:39, F/M:36/3). The diagnosis of Hashimoto thy-
roiditis was based on the standard clinical criteria, thyroid function
tests of autoantibody levels, and thyroid ultrasonography imaging
(13). Serum free T3 (fT3) and free T4 (fT4) were measured with a
competitive enzyme immunoassay. Serum TSH, thyroid peroxidase
antibody (TPOAb) and thyroglobulin antibody (TgAb) levels were
measured using two-site immunoenzymometric assay. The pres-
ence of dry eye syndrome was compared between each group.
Ocular Surface Disease Index (OSDI ) questionnaire, tear break-up
time (TBUT ) and Schirmer I tests were applied for the clinical eval-
uation of dry eye syndrome.
Ocular Surface Disease Index (OSDI ) questionnaire: The presence
and the severity of the dry eye symptoms related to ocular irritation
were evaluated with the scoring system of OSDI questionnaire.
OSDI questionnaire consisted of twelve questions and three cate-
gories namely, ocular symptoms, visional functions, and environ-
mental factors. The patients scored each symptom in all the
categories, between 0–4 according to their frequencies and sever-
ities (0: never, 4: most often) (14). OSDI score was calculated with
the standardized formula: Total score  25/number of valid ques-
tions. The scores were defined as normal (0–12.5) or abnormal
(>12.5), with mild (12.5–27.8), moderate (27.8–75) to severe (75–
100) dry eye symptom, in a scoring system having a range of 0–
100. The mean OSDI score was compared between each group 
Measurement of tear break-up time (TBUT ): A strip moistened with
fluorescein sodium was applied to the inferior conjunctival region in
each eye of the patient. After the strip was removed, the patient
was asked to blink for three times in order to gain a homogenous
distribution. The time interval between the initial break-up and the
formation of the first rupture of the tear film was recorded three
times and the average of the measurements was recorded
as TBUT score. 
Measurement of Schirmer I: A no. 41 Whatman filter strip was
placed on the mid and lateral junction of the inferior fornix and the
process was carried out in a dim environment without stimulant of
light. No topical anesthesia was used prior to the evaluation. After
5 min, the strips were removed and the wet part of the strip was
measured in millimeters to define Schirmer scores. The results
below 5 mm were accepted as a strong indication for dry eye syn-
drome and results below 10 mm were defined as aqueous tear
deficiency. Diagnosis of dry eye syndrome was established in pa-
tients with abnormal OSDI scores (>12.5) and Schirmer I result
below 10 mm or TBUT below 10 s; or patients with normal Schirmer
I and TBUT results but who had moderate or severe levels of OSDİ
scores; or patients with a Schirmer score of below 5 mm. OSDI
questionnaires, TBUT, and Schirmer I tests were evaluated and per-
formed at a single center by the same ophthalmologist, for each
patient. This study was approved by the ethics committee of our
hospital and a written informed consent was obtained from all par-
ticipants. All the procedures were performed in accordance with
the Declaration of Helsinki.
Statistical Analysis
The distribution of variables was evaluated using the Kolmogorov
Smirnov test. The mean, standard deviation [SD], median, mini-
mum, maximum, frequency and percentage values were reported
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for each data. All the between-group comparisons were analyzed
using ANOVA and post-hoc Tukey‘s test. Kruskal-Wallis test, chi-
square test, and Spearman’s test were performed for the analysis
of OSDI scores, categorical variables, correlation, respectively, with
a statistical significance of p <0.05. All the statistical calculations
were performed with SPSS 22.0 Package.
Results 
The study included patients who were recently diagnosed with
Hashimoto thyroiditis (n:125, F:115, M:10) and had euthyroidism
(n:48, 38.4%), subclinical hypothyroidism (n:38, 30.4%) or overt
hypothyroidism (n:39, 31.2%) according to their baseline thyroid
functions. The mean age of the patients was 39.3 ±11.8 (18–75;
38 years) and mean TSH level was 10.1 ±16.4 (0.1– 100; 5 mIU/L)
(mean ±s.d, min-max; median). The distribution of age, duration
of diagnosis and levels of TSH, fT4, fT3, and autoantibody ac-
cording to thyroid function status, are summarized in Table 1. The
median value of OSDI questionnaire score was 9 (24.4 ±19.5;
0.0–90). OSDI was evaluated as normal in 33.6% of the patients
(n:42) while in the remaining, the scores indicated the presence
of mild (29.6%, n:37) or moderate (36.8%, n:46) dry eye symp-
toms. There were no significant differences between the Schirmer
test results (p = 0.6) and TBUT values (p = 0.2)
between the three groups (Table 2). Mean values of OSDI scores
were similar in euthyroid (23.7), subclinical (24.8) and overt hy-
pothyroid patients (25.1). However, when the severity of OSDI
scores was compared between the three groups of patients with
dry eye diagnosis, euthyroidism tended to be mostly related with
milder scores, while the patients with subclinical or overt hy-
pothyroidism were more prone to having higher results (p=0.03)
in the OSDI questionnaire (Table 2). Dry eye syndrome diagnosis
based on OSDI score, Schirmer test and tear break-up time, did
not show any significant difference between the three groups
Euthyroidism Subclinical Hypothyroidism Overt Hypothyroidism
Median, mean ±SD n: 48 (38.4%) n:38 (30.4%) n: 39 (31.2%) p
Age 39.5, 37.0, 37.1, 0.7
40.3 ± 10.5  38.6 ± 12.0 38.6 ± 13.1
Duration of Diagnosis (years) 3.7 ± 1.81 3.3± 2.1 3.8 ± 1.83 0.2
TSH 2.1, 5.8, 13.8, 0.001*
1.9 ± 1.1 6.1 ± 1.3 24.3 ± 23.8
fT4 1.34, 1.17, 0.88, 0.3
1.21±0.28 1.13±0.26 1.07±0.32
fT3 2.98 2.93 2.83, 0.4
3.0±0.61 3.0±0.37 2.7±0.51
Anti Tg 232.7, 242.5, 376.9, 0.06
282.7 ± 271.4 531.2 ± 925.1 920.1 ± 1361.8
Anti  TPO 269.3, 194.7, 473.9, 0.01°
265.8 ± 192.2 228.3 ± 168.1 381.9 ± 220.5
TSH: Thyroid stimulating hormone,  fT4: free T4, fT3: free T3, Anti Tg: antithyroglobulin antibody, Anti TPO: anti-thyroid peroxidase antibody. *post hoc analysis is signicant
between overt hypothyroidism-euthyroidism and overt hypothyroidism-subclinical hypothyroidism.  ° post hoc analysis is signicant between overt hypothyroidism and
subclinical hypothyroidism.
Table 1. The distribution of age, duration of diagnosis, and laboratory results according to thyroid status.
Euthyroidism Subclinical Hypothyroidism Overt Hypothyroidism
Median, mean ±SD n: 48 (38.4%) n:38 (30.4%) n: 39 (31.2%) p
OSDI score in patients with 13.5, 17.7, 32.2, 0.03*
dry eye diagnosis 19.7 ± 20.3 28.6 ± 19.1 38.1 ± 19.5
Schirmer's (mm) 24, 23, 21, 0.6
20.6 ± 8.7 21.6 ±9.9 19.2 ±10.2
Tear Break-Up Time (sec.) 10.5, 10, 10, 0.2
10.4 ±2.0 10.1 ±2.3 9.7 ±2.4
Palpebral Angle (mm) 10.4, 10.1, 9.8 0.2
11.04 ±1.22 10.69 ±1.49 10.38 ±2.03
OSDI: Ocular Surface Disease Index, * post hoc analysis is signicant between overt hypothyroidism and euthyroidism.
Table 2. Distribution of OSDI scores, Schirmer's test, tear break-up time and palpebral angle according to thyroid status.
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(p=0.1). Spearman’s correlation analysis revealed the presence of
negative correlation between fT3 levels and dry eye diagnosis (p
= 0.03, r= –0. 98) and plasma fT3 levels were seen to positively
correlate with TBUT values (p = 0.004, r = 0.30). The decrease in
fT3 levels resulted in a decrease of TBUT scores and an increase
in the frequency of dry eye diagnosis (Table 3). Even though there
was no significant correlation between OSDI scores and the re-
sults of Schirmer or TBUT tests, a significant correlation (p = 0.001,
r = 0.685) was seen between OSDI scores and dry eye diagno-
sis, as predicted (Table 3). 
Discussion
Dry eye syndrome has been linked to Hashimoto thyroiditis, with
decreased Schirmer test results, TBUT measurements and higher
OSDI scores (15). The risk factors for the development of dry eye
are decreased fT4 levels and the presence of proptosis. In order to
decrease the prevalence of dry eye in these patients, levothyroxine
treatment was formerly recommended (15). This study revealed a
similar frequency of dry eye syndrome diagnosis among patients
with hashimoto thyroiditis irrespective of their thyroid function sta-
tus. Similarly, the frequency of the presence of dry eye was com-
parable between the groups, which was independent of the
patient’s thyroid function status. Additionally, there was no signifi-
cant correlation between dry eye and fT4 levels, but fT3 levels
showed a significant negative correlation with dry eye syndrome
and positive correlation with TBUT. The decrease in fT3 levels re-
sulted in lower TBUT measurements and increased dry eye diag-
nosis. This relation may be explained by the fact that most of the
effects of thyroid hormones on peripheral receptors are mediated
by fT3 levels (16). 
The etiopathogenesis of dry eye syndrome related with TAO have
been investigated in several recent studies (7, 9–12). One of the
main factors is an increase in tear film evaporation due to propto-
sis which subsequently causes tear hyperosmolarity and a de-
creased TBUT (17,18). Tear film hyperosmolarity has been shown
to induce dry eye syndrome via inflammatory processes by induc-
ing several inflammatory cytokines such as Interleukin-1 (IL- 1), TNF-
α and MMP-9 (19). It has been reported that tear hyperosmolarity
causes dry eye syndrome because of ocular surface damage,
which activates mitogen active protein kinase signal (MAPK) path-
ways and induces MMP-9 expression (19, 20). In 1983 Gilbard et al.
showed that tear osmolarity was significantly elevated in patients
with dry eye syndrome and TAO (12). Proptosis and increase in
palpebral angle are few of the many responsible factors in the de-
velopment of the dry eye in TAO, particularly in Graves’s disease.
However, a previous study demonstrated that the presence of sig-
nificant ocular surface inflammation and dry eye symptoms in pa-
tients with Graves’s disease was not dependent on either the
degree of proptosis or the palpebral angle measurement (21). The
presence of inflammation was seen with diffused lymphocyte infil-
tration and grade 2–3 metaplasia, in the temporal interpalpebral
region. This proved that ocular inflammation is also responsible for
the development of dry eye syndrome, which is independent of the
degree of proptosis (21).
The majority of the studies pertaining to dry eye syndrome and
TAO have been conducted with Graves patients (7,9,11,12) and it
has been seen that the studies on Hashimoto thyroiditis are
rather limited (12,15). Previous experiments have shown that
chronic deficiency of thyroid hormones causes ocular surface ab-
normalities and dry eye syndrome (10). In 2007, Dias et al. sug-
gested that lacrimal glands express receptors of thyroid hormone
β-1 (Thrb), due to which they become a target tissue for thyroid
hormones and thereby are susceptible to hypothyroidism. Fur-
thermore, the chronic deficiency of thyroid hormones has been
shown to be related to a modification in Thrb receptor expres-
sion, leading to diminished tear secretion and dry eye syndrome
(10). 
Thyroid hormone regulates the oxidative metabolism through its
nuclear Thrb receptors and therefore chronic hypothyroidism re-
sults in increased oxidative stress (22,23). Immunohistochemical
analysis indicates the presence of Thrb receptors in the acinar
and ductal cells of lacrimal glands and in the nuclei of epithe-
lial cells that line the corneal and conjunctival surface and it has
been seen that these receptors are upregulated during hypothy-
roidism (10). Hence, the presence of hypothyroidism may have an
adverse effect on lacrimal gland as well as corneal and conjuncti-
val epithelial cells which are susceptible to low thyroid hormone
levels (via Thrb receptors). The upregulation of these receptors is
considered to be a compensatory mechanism, which is irreversible
OSDI Score   Schirmer's test (mm) Tear Break Up Time (sec)    Dry eye 
Anti Tg p=0.6 r=0.04 0.3 0.12 0.7 0.03 0.4 0.69 
Anti TPO 0.1 –0.14 0.5 0.06 0.7 –0.03 0.2 0.12
TSH 0.5 –0.05 0.8 0.02 0.1 –0.14 0.2 0.12
fT4 0.9 0.01 0.1 –0.17 0.8 0.02 0.1 –0.13 
fT3 0.7 –0.03 0.1 0.16 0.004 0.30 0.03 –0.19 
Age 0.2 0.11 0.1 –0.15 0.7 –0.03 0.1 0.14 
OSDI Score 0.2 0.12 0.8 –0.01 0.001 0.68
Anti Tg: antithyroglobulin antibody, Anti TPO: anti-thyroid peroxidase antibody
fT4: free T4, fT3: free T3, TSH: thyroid stimulating hormone, OSDI: Ocular Surface Disease Index.
Table 3. Correlation of clinical and laboratory parameters with dry eye syndrome.
in nature, as the number of receptors does not return to baseline
levels even after the improvement of hypothyroidism (10). This could
be the reason for the similar rates of dry eye syndrome that was
observed in our patients who had different thyroid hormone lev-
els. The similar frequencies of dry eye symptoms in euthyroid pa-
tients may be due to the persistent upregulation of the Thrb
receptors which had occurred during an early period of hypothy-
roidism. 
Moreover, our study also revealed that the patients with euthy-
roidism, who were also diagnosed with dry eye syndrome, were
more prone to obtain lower scores on OSDI questionnaire,
whereas patients with subclinical or overt hypothyroidism tended
to get higher scores that indicated severe dry eye symptoms. This
implied that even though the frequency of dry eye syndrome was
similar between each group, euthyroid patients had milder dry eye
symptoms with lower OSDI scores. The amelioration in the symp-
toms might have been due to improvement in Thrb receptor up-
regulation. Nevertheless, further clinical and experimental studies
with wider patient series are needed in order to reach definitive
conclusions. 
The limitation of our study was that exophthalmometer meas-
urements of the patients could not be performed because of
technical difficulties. It is possible that the improvement in the
proptosis also had an effect on the amelioration of dry eye
symptoms. It has been shown that the improvement of thyroid
functions, which results in lowering of intraorbital glycosamino-
glycan levels, may resolve the proptosis and palpebral angle
widening (8). However, no statistically significant difference was
found in the palpebral angle measurements between the three
groups. 
Conclusion
Dry eye is a common clinical problem seen during the manage-
ment of hypothyroidism. Thus, ocular symptoms and signs
should also be evaluated carefully in the surveillance of patients
with Hashimoto thyroiditis. Levothyroxine replacement therapy
not only improves several clinical factors but also provides ben-
efit in the clinical care of these patients by alleviating the dry eye
symptoms and improving daily activities. Further studies with
wider population groups are needed in order to understand 
and improve the quality of life in patients with Hashimoto thy-
roiditis.
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